Calithera Biosciences is a San Francisco-based clinical-stage biopharmaceutical company pioneering the discovery and development of targeted, small-molecule therapies that disrupt cellular metabolic pathways to preferentially block tumor cell growth and enhance immune-cell activity. Today, the company received a new research award […]